A detailed history of Voya Investment Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Voya Investment Management LLC holds 1,912,021 shares of EW stock, worth $130 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,912,021
Previous 3,199,613 40.24%
Holding current value
$130 Million
Previous $296 Million 57.31%
% of portfolio
0.16%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $76.9 Million - $121 Million
-1,287,592 Reduced 40.24%
1,912,021 $126 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $11.1 Million - $12.5 Million
-132,220 Reduced 3.97%
3,199,613 $296 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $221 Million - $292 Million
3,051,464 Added 1088.37%
3,331,833 $318 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $311,203 - $392,143
5,043 Added 1.83%
280,369 $21.4 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $297,419 - $400,880
-4,293 Reduced 1.54%
275,326 $19.1 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $1.19 Million - $1.38 Million
14,592 Added 5.51%
279,619 $26.4 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $565,786 - $643,881
7,619 Added 2.96%
265,027 $21.9 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $65.1 Million - $83.3 Million
-953,167 Reduced 78.74%
257,408 $19.2 Million
Q3 2022

Mar 03, 2023

BUY
$82.37 - $107.29 $78.5 Million - $102 Million
953,167 Added 370.29%
1,210,575 $100 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $660,195 - $859,929
-8,015 Reduced 0.66%
1,210,575 $100 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $79.4 Million - $118 Million
917,906 Added 305.27%
1,218,590 $116 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $934,361 - $1.18 Million
-9,164 Reduced 2.96%
300,684 $35.4 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $2.95 Million - $3.63 Million
27,769 Added 9.84%
309,848 $40.1 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $1.02 Million - $1.21 Million
9,882 Added 3.63%
282,079 $31.9 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $7.74 Million - $9.68 Million
-92,359 Reduced 25.33%
272,197 $28.2 Million
Q1 2021

May 17, 2021

SELL
$78.68 - $90.67 $3 Million - $3.45 Million
-38,083 Reduced 9.46%
364,556 $30.5 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $158,148 - $201,253
2,206 Added 0.55%
402,639 $36.7 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $5.17 Million - $6.73 Million
76,989 Added 23.8%
400,433 $32 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $12.8 Million - $17.1 Million
221,835 Added 218.32%
323,444 $22.4 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $197,218 - $304,803
3,763 Added 3.85%
101,609 $19.2 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $1.04 Million - $1.19 Million
14,471 Added 17.36%
97,846 $22.8 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $4,985 - $6,109
-81 Reduced 0.1%
83,375 $18.3 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $35.9 Million - $41.4 Million
-643,485 Reduced 88.52%
83,456 $15.4 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $571,902 - $764,885
-11,942 Reduced 1.62%
726,941 $139 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $9.3 Million - $11.4 Million
-200,461 Reduced 21.34%
738,883 $113 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $1.28 Million - $1.63 Million
28,106 Added 3.08%
939,344 $164 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $12.5 Million - $15.1 Million
295,113 Added 47.9%
911,238 $133 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $379,672 - $484,417
-10,209 Reduced 1.63%
616,125 $86 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $700,534 - $816,633
-20,732 Reduced 3.2%
626,334 $70.6 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $23.5 Million - $25.1 Million
647,066
647,066 $70.7 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.